L-arginine/nitric oxide pathway modulates gastric motility and gallbladder emptying induced by erythromycin and liquid meal in humans
- PMID: 7781462
- DOI: 10.1007/BF02065553
L-arginine/nitric oxide pathway modulates gastric motility and gallbladder emptying induced by erythromycin and liquid meal in humans
Abstract
There is recent evidence that nitric oxide, a soluble gas produced from L-arginine, is released by the smooth muscle cells and neurons of the gastrointestinal tract where it exerts a myorelaxive action. However, little is known about the effects nitric oxide has on gastric and gallbladder motility during the inter- and postprandial phases in man. We therefore investigated the effects 200 mg/kg/hr L-arginine exerts on the gastric and gallbladder motility induced by 2 mg/kg erythromycin or a liquid meal in 21 subjects in a double-blind, placebo-controlled study. Gastric and gallbladder emptying were evaluated by sonography. Fasting antral motility was expressed as antral motility index (MI). In fasting subjects, L-arginine administration determined a threefold increase in plasma nitrite concentrations. Administration of erythromycin caused a significant rise in the antral MI, which was inhibited by L-arginine (P < 0.05). Ingestion of a liquid meal also significantly increased antral MI, but it returned to basal values 90 min after the end of the meal. Although L-arginine administration caused a significant reduction in the antral MI (P < 0.05), it did not inhibit gastric emptying. L-Arginine provoked an approximately 40% increase in basal gallbladder volume, completely blocked erythromycin-induced emptying, and partially, but significantly, prevented the emptying induced by a liquid meal (P < 0.01). Our study suggests that nitric oxide may be implicated in the physiological modulation of gastric and gallbladder motility during the inter- and postprandial phases in man.
Similar articles
-
Effects of nitric oxide on antral motility and gastric emptying in humans.Eur J Gastroenterol Hepatol. 1995 Feb;7(2):97-102. Eur J Gastroenterol Hepatol. 1995. PMID: 7712314 Clinical Trial.
-
Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.Scand J Gastroenterol. 1994 Sep;29(9):807-13. doi: 10.3109/00365529409092515. Scand J Gastroenterol. 1994. PMID: 7824860 Clinical Trial.
-
Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.Am J Gastroenterol. 1994 Apr;89(4):550-5. Am J Gastroenterol. 1994. PMID: 8147358
-
Georges Brohee Prize 1994. Motilin and the enteric nervous system in the control of interdigestive and postprandial gastric motility.Acta Gastroenterol Belg. 1995 Jan-Feb;58(1):21-30. Acta Gastroenterol Belg. 1995. PMID: 7604665 Review.
-
Factors affecting gallbladder motility: drugs.Dig Liver Dis. 2003 Jul;35 Suppl 3:S17-9. doi: 10.1016/s1590-8658(03)00088-4. Dig Liver Dis. 2003. PMID: 12974504 Review.
Cited by
-
Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.Gut. 1998 Jun;42(6):830-5. doi: 10.1136/gut.42.6.830. Gut. 1998. PMID: 9691922 Free PMC article. Clinical Trial.
-
Effects of intragastric L-arginine administration on proximal stomach tone under basal conditions and after an intragastric diet.Dig Dis Sci. 2006 Dec;51(12):2147-53. doi: 10.1007/s10620-006-9393-9. Epub 2006 Nov 14. Dig Dis Sci. 2006. PMID: 17103307 Clinical Trial.
-
L-arginine promotes gut hormone release and reduces food intake in rodents.Diabetes Obes Metab. 2016 May;18(5):508-18. doi: 10.1111/dom.12644. Epub 2016 Apr 1. Diabetes Obes Metab. 2016. PMID: 26863991 Free PMC article.
-
Pharmacological activity of ruthenium complexes trans-[RuCl(2)(L)4] (l = nicotinic or i-nicotinic acid) on anxiety and memory in rats.Neurochem Res. 2006 Dec;31(12):1457-62. doi: 10.1007/s11064-006-9198-4. Epub 2006 Nov 15. Neurochem Res. 2006. PMID: 17106655